AI assistant
Sending…
Unichem Laboratories Ltd. — Major Shareholding Notification 2023
Jun 19, 2023
61109_rns_2023-06-19_160e7f5b-0d83-4523-97b7-63707e596a9d.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Disclosures under Regulation 29 (2) of SEBI (Substantial Acquistion of Shares and Takeovers) Regulations, 2011
| Name of the Target Company (TC) | Unichem Laboratories Ltd. | ||
|---|---|---|---|
| Name(s) of the acquirer and Persons Acting in Concert (PAC) with the acquirer |
Portfolio Management clients of Equity Intelligence India Pvt Ltd and EQ India Fund |
||
| Whether the acquirer belongs to Promoter/ Promoter group | No | ||
| Name (s) of the Stock Exchange(s) where the shares of TC are Listed |
NSE and BSE | ||
| Details of the acquisition/ disposal as follows | Number | % w.r.t. total share/voting capital wherever applicable (*) |
% w.r.t. total diluted share/ voting capital of the TC $(**)$ |
| Before the acquisition-/ sale under consideration, holding of: | |||
| a) Shares carrying voting rights b) Shares in the nature of encumbrance (Pledge/lien/non- disposal undertakings/others) c) Voting rights (VR) otherwise than by shares |
21,55,675 | 3.06 | N.A |
| d) Warrants/convertible securities/ any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) |
|||
| e) Total (a+b+c+d) | 21,55,675 | 3.06 | N.A |
| Details of acquisition / sale | |||
| a) Shares carrying voting rights acquired / sold b) VRs acquired / sold otherwise than by shares c) Warrants/convertible securities/ any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired / sold |
1,02,300 | 0.14 | N.A |
| d) Shares encumbered / invoked / released by the acquirer | |||
| e) Total (a+b+c+d) | 1,02,300 | 0.14 | N.A |
| After the acquisition / sale, holding of: | |||
| a) Shares carrying voting rights b) Shares encumbered with the acquirer c) VRs otherwise than by shares |
20,53,375 | 2.92 | N.A |
| d) Warrants/convertible securities/ any other instrument that entitles the acquirer to receive shares carrying voting rights in |
|||
| the TC (specify holding in each category) after the acquisition | N.A | ||
| e) Total (a+b+c+d) | 20,53,375 | 2.92 | N.A |

| Mode of acquisition / sale (e.g. Open market / off-market/ public issue / rights issue/ preferential allotment/ inter-se |
|
|---|---|
| transfer/etc). | Open Market |
| Date of acquisition / sale of shares/ VR or date of receipt of | |
| intimation of allotment of shares, whichever is applicable | 15-06-2023 |
| Equity share capital / total voting capital of the TC before the | |
| said acquisition/sale | 7,04,05,750 Equity Shares of Rs.2/ each |
| Equity share capital / total voting capital of the TC after the | |
| said acquisition/sale | 7,04,05,750 Equity Shares of Rs.2/ each |
| Total diluted share / voting capital of the TC after the said | |
| acquisition | N.A |
For Equity/Intelligence India Pvt Ltd
Abhilash Varghese Director-Operations

Place: Kochi Date: June 19, 2023
Note:
(*) Total share capital/voting capital to be taken as per the latest filing done by the company to the stock exchange under Clause 35 of the listing Agreement.
(**) Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/ warrants into equity shares of the TC.
More from Unichem Laboratories Ltd.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 27
Report Publication Announcement
2026
May 23
Earnings Release
2026
May 23
Interim / Quarterly Report
2026
May 22
Interim / Quarterly Report
2026
May 22
Interim / Quarterly Report
2026
May 22